These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 342319

  • 1. HI antibody response in volunteers vaccinated with live influenza A/New Jersey/76 vaccine.
    Ikić D, Smerdel S, Manhalter T, Pasini N, Delimar N.
    Dev Biol Stand; ; 39():67-71. PubMed ID: 342319
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of influenza A/New Jersey/76 virus strain, preparation of live vaccine and vaccine reactogenicity in volunteers.
    Ikić D, Pasini N, Hećimović M, Juzbasić M, Smerdel S, Rajner N, Jelavić V.
    Dev Biol Stand; ; 39():61-5. PubMed ID: 342318
    [Abstract] [Full Text] [Related]

  • 3. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
    Hrabar A, Vodopija I, André FE, Mitchell JR, Maassab HF, Hennessy AV, Davenport FM.
    Dev Biol Stand; ; 39():53-60. PubMed ID: 342317
    [No Abstract] [Full Text] [Related]

  • 4. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S, Süss J, Oehring H, Schmidt J.
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [Abstract] [Full Text] [Related]

  • 5. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
    Noble GR, Kaye HS, O'Brien RJ, Kendal AP, Bregman DJ, Wright PF, Amler RW, Dowdle WR.
    Dev Biol Stand; 1982 Dec; 39():253-60. PubMed ID: 604107
    [Abstract] [Full Text] [Related]

  • 6. Augmentation of hemagglutination-inhibition (HI) antibodies in gilts of breeding age by large dosages of human A/New Jersey/76 influenza vaccine.
    Woods GT, Mansfield ME.
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):399-402. PubMed ID: 461965
    [Abstract] [Full Text] [Related]

  • 7. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 8. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW, Contreras G, Furesz J.
    Can Med Assoc J; 1979 Apr 07; 120(7):799-802, 831. PubMed ID: 427686
    [Abstract] [Full Text] [Related]

  • 9. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.
    J Med Virol; 2007 Mar 07; 79(3):320-5. PubMed ID: 17245715
    [Abstract] [Full Text] [Related]

  • 10. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG, Freestone DS, Bowker CH, Barnes GM, Letley E, Ferris RD.
    Dev Biol Stand; 1976 Mar 07; 33():202-6. PubMed ID: 782970
    [Abstract] [Full Text] [Related]

  • 11. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 07; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 12. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C, Hofmann H, Bachmayer H, Liehl E, Moritz AJ.
    Dev Biol Stand; 2006 Sep 07; 39():297-302. PubMed ID: 342311
    [Abstract] [Full Text] [Related]

  • 13. A trial of live virus intra-nasal influenza vaccine.
    Dodge JS.
    N Z Med J; 1978 Feb 08; 87(605):79-82. PubMed ID: 273801
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 08; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM, McCahon D, Freestone DS.
    Dev Biol Stand; 1976 Jul 08; 33():191-6. PubMed ID: 955267
    [Abstract] [Full Text] [Related]

  • 16. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
    Levine M, Beattie BL, McLean DM.
    CMAJ; 1987 Oct 15; 137(8):722-6. PubMed ID: 3651943
    [Abstract] [Full Text] [Related]

  • 17. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 18. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J.
    Arch Immunol Ther Exp (Warsz); 1996 Sep 08; 44(5-6):389-94. PubMed ID: 9017157
    [Abstract] [Full Text] [Related]

  • 19. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar 08; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.
    Clin Infect Dis; 2009 Apr 15; 48(8):1087-95. PubMed ID: 19281330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.